Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…
Read More »healthcare
China enjoys world-class transport infrastructure and mobile and internet coverage. The remarkably low headline consumption rate is simply at odds…
Read More »
Three hospital systems across England have begun a live clinical trial of AI technology designed to detect and grade prostate…
Read More »
An MSCI index tracking 81 Chinese health care stocks with a combined market value of HK$1.15 trillion (US$148 billion) advanced…
Read More »